2. Cash, Cash Equivalents and Marketable Securities (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
|---|
| Cash, Cash Equivalents, and Short-Term Investments [Abstract] |
|
| Schedule of Cash, Cash Equivalents, and Marketable Securities |
Cash, cash equivalents, and marketable securities consisted of the following at March 31, 2025 and December 31, 2024 (in thousands): | | | | | | | | | | | | | | | | | March 31,
2025 | | December 31,
2024 | | Cash and cash equivalents: | | | | | | Cash | | $ | 591,907 | | | $ | 1,094,796 | | | Money market funds | | 245,734 | | | 526,580 | | | Total cash and cash equivalents | | 837,641 | | | 1,621,376 | | | Marketable securities: | | | | | | Time deposits | | 44,199 | | | 162,836 | | | U.S. debt | | 8,920 | | | 8,747 | | | Total marketable securities | | 53,119 | | | 171,583 | | | Total cash, cash equivalents, and marketable securities | | $ | 890,760 | | | $ | 1,792,959 | |
|
| Reconciliation of Cash, Cash Equivalents, and Restricted Cash |
The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents reported within our condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024 to the total of such amounts as presented in the condensed consolidated statements of cash flows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Balance Sheet Line Item | | March 31,
2025 | | December 31,
2024 | | Cash and cash equivalents | | Cash and cash equivalents | | $ | 837,641 | | | $ | 1,621,376 | | Restricted cash – current | | Other current assets | | — | | | 8,262 | | Restricted cash – noncurrent | | Other assets | | 3,618 | | | 3,613 | | | Restricted cash equivalents – noncurrent | | Other assets | | 2,761 | | | 4,972 | | | Total cash, cash equivalents, restricted cash, and restricted cash equivalents | | | | $ | 844,020 | | | $ | 1,638,223 | |
|
| Available-for-sale Marketable Securities |
The following tables summarize the unrealized gains and losses related to our available-for-sale marketable securities, by major security type, as of March 31, 2025 and December 31, 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2025 | | | Amortized
Cost | | Unrealized
Gains | | Unrealized
Losses | | Fair
Value | | Time deposits | | $ | 44,199 | | | $ | — | | | $ | — | | | $ | 44,199 | | | U.S. debt | | 10,000 | | | — | | | 1,080 | | | 8,920 | | | Total | | $ | 54,199 | | | $ | — | | | $ | 1,080 | | | $ | 53,119 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | Amortized
Cost | | Unrealized
Gains | | Unrealized
Losses | | Fair
Value | | Time deposits | | $ | 162,836 | | | $ | — | | | $ | — | | | $ | 162,836 | | | U.S. debt | | 10,000 | | | — | | | 1,253 | | | 8,747 | | | Total | | $ | 172,836 | | | $ | — | | | $ | 1,253 | | | $ | 171,583 | |
|
| Available-for-sale Marketable Securities by Maturity |
The contractual maturities of our marketable securities as of March 31, 2025 were as follows (in thousands): | | | | | | | | | | | Fair
Value | Within one year | | $ | 49,018 | | After one year through five years | | — | | After five years through ten years | | 4,101 | | | Total | | $ | 53,119 | |
|